20911 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
Compositions and Methods for Elimination of Unwanted Cells
#602Tumor cytotoxicity induced by modulators of the CXCR4 receptor
#603Compositions and Methods for Elimination of Unwanted Cells
#604Mutated HIV Nef for modulating immunity
#605Methods for treatment or prophylaxis of atherosclerosis and reperfusion injury
#606VP1 of foot-and-mouth disease virus
#607Apoptosis-inducing polypeptides
#608Compositions and Methods for Elimination of Unwanted Cells
#609Compositions and methods for elimination of unwanted cells
#610Pneumovirus NS proteins antagonize the interferon IFN response
#611Method and Composition for Treatment of Neoplasms
#612Apoptosis-inducing polypeptides
#613Decorin gene delivery system and cancer treatment
#614Agents for treatment of HCV and methods of use
#615TREATMENT OF RHEUMATOID ARTHRITIS WITH SOLUBLE FAS-LIGAND CROSS-LINKERS
#616Influenza A virus vaccines and inhibitors
#617Human cytomegalovirus immunotherapy
#618Apoptin-associating protein
#619Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
#620Viral complement control proteins for eye disorders
#621Human papilloma virus treatment
#622Fusion proteins comprising flagellin and dengue viral envelope proteins
#623Peptide Derived From Hepatitis C Virus
#624Apoptin-associating protein
#625Tat-Based Tolerogen Compositions and Methods of Making and Using Same
#626METHODS FOR TREATING SEPTIC SHOCK
#627Compositions And Methods For Modification And Prevention Of Sars Coronavirus Infectivity
#628ADENOVIRUS FIBER SHAFT COMPOSITION AND METHODS OF USE
#629Stabilizing alkylglycoside compositions and methods thereof
#630Modified VP1-capsid protein of parvovirus B19
#631Human papillomavirus polypeptides and immunogenic compositions
#632Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#633Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B
#634NOVEL NANOPARTICLES AND USE THEREOF
#635Protein inhibitor of Ran activity and methods of use thereof
#636Use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses
#637Treatment of spinal cord injury
#638ANTIVIRAL AGENTS FOR THE TREATMENT, CONTROL AND PREVENTION OF INFECTIONS BY CORONAVIRUSES
#639Thermoprotective compositions of pkg pathway inhibitors and method of use thereof
#640Interferon antagonists useful for the treatment of interferon related diseases
#641Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell
#642Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses
#643Immunomodulatory compositions and uses therefor
#644Method for the recombinant expression of a polypeptide
#645Treatment of rheumatic diseases
#646Peptide pharmaceutical compositions
#647Compositions comprising a fragment of the herpesviral protein vp22 for delivery of substances to cells
#648Antigen arrays for treatment of allergic eosinophilic diseases
#649Short RNA-binding proteins
#650Expression of virus entry inhibitors and recombinant AAV thereof
#651Flavivirus NS5A proteins for the treatment of HIV
#652Tumor treatment using beta-sheet peptides and radiotherapy
#653Compositions for modulating immune cell activity and methods for detection thereof
#654Mapping and reconstitution of a conformational discontinuous binding surface
#655Therapeutic peptides and vaccines
#656Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41
#657Influenza virus inhibiting peptides
#658Compositions and methods of treating HIV infections
#659Antiviral agents for the treatment, control and prevention of infections by coronaviruses
#660Epstein-barr-virus-specific immunization
#661Preparation of a peptide compound (SYRAPRO-2000) and its use for the activation of protein phosphatase-2A1 enzyme
#662Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
#663Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
#664MCV MC160 compositions and methods
#665Novel uses of parapoxvirus preparations
#666Compositions and methods for the inhibition of membrane fusion by paramyxoviruses
#667Polypeptide transduction and fusogenic peptides
#668Methods and compositions for inhibiting stat signaling pathways
#669Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease
#670Multiple branch peptide construction
#671Viral complement control proteins for eye disorders
#672Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
#673Dc-sign blockers and their use for preventing or treating viral infections
#674Method of modulating cellular activity and molecules for use therein
#675Methods of identifying and isolating cells expressing DC-sign
#676Combination gene delivery vehicles
#677Protein and peptide expression for passive immunity
#678Methods and compositions for inhibiting hiv-coreceptor interactions
#679Compositions and methods for modifying toxic effects of proteinaceous compounds
#680Inhibitors of hepatitis C virus
#681Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses
#682Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses
#683Method of cell growth inhibition with agnoprotein
#684Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods
#685Compositions and methods for elimination of unwanted cells
#686Biologically active compounds for the modification of bodily odours
#687Use of HCV proteins
#688Human papillomavirus polypeptides and immunogenic compositions
#689Five-Helix protein
#690Fc chimeric proteins with anti-HIV drugs
#691High molecular weight medicine-containing preparation in powder form for administration through mucosa
#692Flavivirus fusion inhibitors
#693Use of apoptosis inducing agents in the treatment of (auto) immune diseases
#694Methods and compositions for use in the treatment of filovirus mediated disease conditions
#695Peptide inhibitors of HIV
#696Tat-based tolerogen compositions and methods of making and using same
#697Method of inducing cell death using West Nile virus capsid protein
#698Variant Tat proteins and methods for use thereof
#699Treatment of rheumatoid arthritis with FLIP antagonists
#700Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
#701Phage-associated lytic enzymes for treatment of and related conditions
#702Method of inhibiting influenza infection with antiviral peptides
#703Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human cytomegalovirus encoded IL-10
#704Methods and compositions for modulating beta-catenin phosphorylation
#705Treatment of rheumatoid arthritis with soluble Fas-ligand cross-linkers
#706Composition for the treatment of infection by Flaviviridae viruses
#707HIV-encoded chemoattractant
#708HCV NS3-NS4A protease resistance mutants
#709Use of bacterial phage associated lysing enzymes for treating various illnesses
#710Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
#711Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication
#712VP22 proteins and uses thereof
#713Compositions of protein mimetics and methods of using same against HIV-1, SARS-coV and the like
#714Human immunodeficiency virus (HIV) gp41 peptide derivatives with enhanced solubility and antiviral activity
#715Compositions of beta-defensin inducing agents
#716Combination method for treating viral infections
#717Apoptosis-inducing polypeptides
#718Method of treating viral infections
#719Atopic dermatitis treatment method
#720Compositions for and methods of treating and preventing sirs/sepsis
#721Surface expression of biologically active proteins in bacteria
#722Fusion peptide inhibitors of human coronavirus 229E
#723Chimeric protein toxins for expression by therapeutic bacteria
#724Microorganisms and methods for producing biologics and introducing biologics to sites
#725TAA/ecdCD40L oncolytic virus
#726Compositions and methods for treating respiratory syncytial virus infection